Physician profile
Carson Day
NPI 1285204339
$3,123.75
in general payments reported to CMS, 2019-2025
19 companies · $1,239 in 2025
The $1,239 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $384 · 2023: $619 · 2024: $882 · 2025: $1,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,740.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $638.26 | 2022-2025 | Total30, Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity |
| Sight Sciences, INC. | $600.85 | 2022-2025 | Tearcare System, Omni Surgical System |
| Abbvie INC. | $413.61 | 2023-2025 | Durysta |
| Bausch & Lomb Americas INC. | $344.37 | 2022-2025 | Vyzulta, Infuse, Miebo |
| Sun Pharmaceutical Industries INC. | $296.01 | 2023-2025 | Cequa |
| Coopervision INC. | $180.30 | 2022-2023 | Clariti Contact Lens, Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $145.55 | 2024-2025 | Xdemvy |
| Ocular Therapeutix, INC. | $139.94 | 2024-2025 | Dextenza |
| Dompe US, INC. | $61.53 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $57.12 | 2023-2024 | Tyrvaya |
| Amgen INC. | $49.58 | 2024-2025 | Tepezza |
| Rxsight INC | $33.67 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Astellas Pharma US INC | $32.07 | 2024 | Izervay |
| Rayner Intraocular Lenses Limited | $31.31 | 2024 | Omidria, Rayone Aspheric, Rayone Emv |
| Harrow Eye, LLC | $21.11 | 2025 | Iheezo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $20.62 | 2025 | Acthar |
| Thea Pharma INC. | $20.40 | 2025 | Iyuzeh |
| Glaukos Corporation | $18.97 | 2025 | Idosetr, Istent Infinite |
| Lkc Technologies, INC. | $18.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.